Each year, influenza vaccines are redesigned to account for virus mutations that reduce the protections people gain from the annual flu shot.
To address these virus mutations, researchers at the Massachusetts Institute of Technology (MIT) and the Ragon Institute of MIT, Mass General Hospital (MGH), and Harvard University announced they are working on strategies for designing a universal flu vaccine that could work against any flu strain.
-
-
COVID-19 Pandemic Challenges Osteoporosis Management
-
AstraZeneca, J&J Resume U.S. COVID-19 Vaccine Trials
-
Survival From COVID-19 High in Patients With Psoriasis
-
FDA Needs More Safety Data on COVID-19 Vaccines, Experts Say
